Exome sequencing and case-control analyses identify RCC1 as a candidate breast cancer susceptibility gene

Int J Cancer. 2018 Jun 15;142(12):2512-2517. doi: 10.1002/ijc.31273. Epub 2018 Feb 5.

Abstract

Breast cancer is a genetic disease but the known genes explain a minority of cases. To elucidate the molecular basis of breast cancer in the Tunisian population, we performed exome sequencing on six BRCA1/BRCA2 mutation-negative patients with familial breast cancer and identified a novel frameshift mutation in RCC1, encoding the Regulator of Chromosome Condensation 1. Subsequent genotyping detected the 19-bp deletion in additional 5 out of 153 (3%) breast cancer patients but in none of 400 female controls (p = 0.0015). The deletion was enriched in patients with a positive family history (5%, p = 0.0009) and co-segregated with breast cancer in the initial pedigree. The mutant allele was lost in 4/6 breast tumors from mutation carriers which may be consistent with the hypothesis that RCC1 dysfunction provides a selective disadvantage at the stage of tumor progression. In summary, we propose RCC1 as a likely breast cancer susceptibility gene in the Tunisian population.

Keywords: RCC1; breast carcinoma; founder mutation; mitosis; replication.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Breast Neoplasms / genetics*
  • Case-Control Studies
  • Cell Cycle Proteins / genetics*
  • Exome / genetics
  • Female
  • Frameshift Mutation
  • Genetic Association Studies
  • Genetic Predisposition to Disease / genetics*
  • Genotype
  • Guanine Nucleotide Exchange Factors / genetics*
  • Humans
  • Middle Aged
  • Nuclear Proteins / genetics*
  • Pedigree
  • Tunisia

Substances

  • Cell Cycle Proteins
  • Guanine Nucleotide Exchange Factors
  • Nuclear Proteins
  • RCC1 protein, human